FDA inspection
ImClone Systems, LLC. d.b.a. Eli Lilly and Company: FDA inspection ending Mar 24, 2016
FDA inspection 971584 · No Action Indicated (NAI) · Branchburg, NJ
Key facts
| Inspection ID | 971584 |
|---|---|
| Firm | ImClone Systems, LLC. d.b.a. Eli Lilly and Company |
| FEI number | 3002889358 |
| Address | 50 Imclone Dr |
| City | Branchburg |
| State | NJ |
| ZIP | 08876-3904 |
| Fiscal year | 2016 |
| Inspection end date | Mar 24, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data